- Home
- ZNTL vs GGZ Comparison
ZNTL vs GGZ Comparison
Compare ZNTL & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- GGZ
- Stock Information
- Founded
- ZNTL 2014
- GGZ 2013
- Country
- ZNTL United States
- GGZ United States
- Employees
- ZNTL N/A
- GGZ N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- GGZ Investment Managers
- Sector
- ZNTL Health Care
- GGZ Finance
- Exchange
- ZNTL Nasdaq
- GGZ Nasdaq
- Market Cap
- ZNTL 105.8M
- GGZ 109.0M
- IPO Year
- ZNTL 2020
- GGZ N/A
- Fundamental
- Price
- ZNTL $1.34
- GGZ $13.37
- Analyst Decision
- ZNTL Buy
- GGZ
- Analyst Count
- ZNTL 7
- GGZ 0
- Target Price
- ZNTL $8.60
- GGZ N/A
- AVG Volume (30 Days)
- ZNTL 772.3K
- GGZ 12.8K
- Earning Date
- ZNTL 08-12-2025
- GGZ 01-01-0001
- Dividend Yield
- ZNTL N/A
- GGZ 5.39%
- EPS Growth
- ZNTL N/A
- GGZ N/A
- EPS
- ZNTL N/A
- GGZ 1.75
- Revenue
- ZNTL $26,865,000.00
- GGZ N/A
- Revenue This Year
- ZNTL N/A
- GGZ N/A
- Revenue Next Year
- ZNTL N/A
- GGZ N/A
- P/E Ratio
- ZNTL N/A
- GGZ $6.79
- Revenue Growth
- ZNTL N/A
- GGZ N/A
- 52 Week Low
- ZNTL $1.01
- GGZ $9.43
- 52 Week High
- ZNTL $5.44
- GGZ $12.50
- Technical
- Relative Strength Index (RSI)
- ZNTL 46.92
- GGZ 46.49
- Support Level
- ZNTL $1.34
- GGZ $13.71
- Resistance Level
- ZNTL $1.48
- GGZ $13.80
- Average True Range (ATR)
- ZNTL 0.08
- GGZ 0.10
- MACD
- ZNTL -0.01
- GGZ -0.03
- Stochastic Oscillator
- ZNTL 21.74
- GGZ 10.68
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About GGZ Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.